Does MPN Change the Outlook After Splanchnic Vein Thrombosis? – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Amica K Ko et al., adding:
“Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study
Does a myeloproliferative neoplasm change the outlook after splanchnic vein thrombosis?
In this large cohort, rates of recurrent thrombosis, bleeding, and survival at six months were similar whether or not patients had an MPN.
The authors suggest MPN-related splanchnic vein thrombosis can be managed much like noncirrhotic, nonmalignant disease, while longer prospective follow-up is still needed.”
Title: Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study
Authors: Amica K Ko, Laura Milana, Nicoletta Riva, Lorenza Bertu, Laurent Bertoletti, Jan Beyer-Westendorf, Marc Carrier, Aurelien Delluc, Elvira Grandone, Pieter Kamphuisen, Alejandro Lazo-Langner, Margherita Maffioli, Daniela Poli, Sam Schulman, Marco Senzolo, Sophie Testa, Alberto Tosetto, Peter Verhamme, Frank W G Leebeek, Sarwa Darwish Murad, Walter Ageno, Mandy N Lauw
Other articles about Journal of Thrombosis and Haemostasis on Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia